Navigation Links
New Clues for Treating Ulcerative Colitis
Date:6/16/2010

Scientists spot chemical tied to remission of the debilitating bowel disease

WEDNESDAY, June 16 (HealthDay News) -- A chemical that may trigger remission in people with ulcerative colitis has been identified by Canadian researchers.

The team at McMaster University in Hamilton, Ontario, found that ulcerative colitis patients in long-term remission have elevated levels of prostaglandin D2. Previous research in rats found that this chemical plays an important role in healing and remission of the disease.

"The levels of prostaglandin D2 were only elevated in those patients in long-term remission, and that suggests it is a key factor in preventing new episodes of ulcerative colitis," John Wallace, director of the Farncombe Family Digestive Health Research Institute at McMaster, said in a university news release.

Wallace, a professor of medicine at the Michael G. DeGroote School of Medicine, said the finding may help lead to a new treatment for ulcerative colitis and possibly to Crohn's disease as well.

Ulcerative colitis involves a chronic inflammation of the inner lining of the rectum and colon that can lead to abdominal pain and cramping, diarrhea, bleeding and weight loss. The condition affects millions of people worldwide. Treatment options are still limited, however, and most people are never cured.

The study was published June 14 in the journal Proceedings of the National Academy of Sciences.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about ulcerative colitis.



-- Robert Preidt



SOURCE: McMaster University, June 14, 2010, news release.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Gene Mutations Offer Clues to Autoimmune Disorders
2. Cysts hold clues to pancreatic cancer
3. Tracking PSA Test Results Over Time Gives Clues to Cancer
4. New Clues to Treating Immune System Disorders
5. New Clues to Treating an Aggressive Breast Cancer
6. Pigs Yield Clues to Cystic Fibrosis-Related Lung Disease
7. New Clues Shed Light on Sperm Function, Male Fertility
8. Ovarian cancer study offers vital clues for new therapies
9. Change in breast density over time provides clues about breast cancer risk
10. Lab that probes genetic clues to disease is poised for major expansion
11. More Clues Emerge on How HIV Infects Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues for Treating Ulcerative Colitis
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: